Author

Steven I. Park

Institution: Wake Forest University

Observed institution: Wake Forest University

OpenAlex ID: A5138799196

Outcomes From the Multicenter ACCRU ‐ LY ‐1804/ CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib‐Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma

2026 · Stephen D. Smith, Suchitra Sundaram, et al. · American Journal of Hematology

Works count: 1

Citation count:

H-index:

I10-index: